Dr. David Brett Kaye, MD

Dr. Kaye practices at Natural Vision in Fresno, California.

Dr. Kaye's NPI, 1124180518, was assigned on December 14, 2006. Dr. Kaye graduated from University of the Witwatersrand in 1969. Dr. Kaye holds California license A325810.

Dr. Kaye's primary practice is Natural Vision, at 6767 N Fresno St, Fresno, CA 93710-3739. The practice phone is (559) 432-1000.

Dr. Kaye's primary practice is Natural Vision in Fresno, California. Dr. Kaye is also affiliated with Community Regional Medical Center. Dmand AI also links Dr. Kaye to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaye practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Kaye's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Kaye is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Kaye's licenses on file in 4 states: California, New York, Illinois and Florida.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and glaucoma among the conditions Dr. Kaye treats.

CMS data shows 3,757 Medicare services from Dr. Kaye across 31 procedure codes in 2024, for 570 Medicare patients. Medicare paid $341,760 for them.

CMS counts 570 Medicare patients who saw Dr. Kaye in 2024. The largest group is 65 to 74, with 278 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 79% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kaye's median patient age at 61, with 54% women.

In 2024, Dr. Kaye wrote 1,209 Medicare Part D claims for 310 patients. 64% of them were for generic drugs. CMS names the drug for 1,147 of them, across 15 drugs with 11 or more claims each, at $100,757 in total drug cost. In 2023, CMS named 1,047 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Kaye for performance year 2024, reported individually. Dr. Kaye accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 71 procedures of cataract surgery by Dr. Kaye, more than 69% of the clinicians it reports for that procedure.

CMS Open Payments shows 32 general payments to Dr. Kaye from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Allergan Inc. paid the most, $201.

Dr. Kaye graduated from University of the Witwatersrand in 1969.

Dr. Kaye is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.